Novel findings about the tafazzin gene offers a potential new target and drug candidate for Barth syndrome.
List view / Grid view
University of Pittsburgh
US researchers use genome sequencing to reveal genetic basis for disabling pansclerotic morphea, a severe inflammatory disease.
US researchers usings a ‘SNAP’ receptor system can customise immunotherapies for targeted treatments of cancer and other diseases.
US researchers have connected a rare T cell called Th9 with treating allergies, testing in mouse models with asthma.
Researchers from the University of Pittsburgh have found that age-associated B cells (ABCs) are key drivers of lupus, a chronic autoimmune disorder that attacks the patient's own organs.
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy
A new study from the University of Pittsburgh and Carnegie Mellon University may solve the puzzle of how cells control their volume.
Scientists at the University of Pittsburgh have been using computational modelling to understand the body’s immune responses to avian flu.
Scientists have identified potential cancer drugs to treat pulmonary hypertension using experimental and computational approaches.
Researchers have found that SARS-CoV-2 evades immune responses by deleting parts of its genetic sequence that encode for the Spike protein.
A novel CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production has been developed to prevent immunity against the gene therapy.
Rodent models of stroke and hydrocephalus treated with ZT-1a had reduced brain swelling, according to scientists.
Scientists have evaluated mouse models used for developing treatments for mood disorders associated with Huntington's disease and have recommended which have greater potential for success.